Acrylamide
This article was originally published in The Rose Sheet
Executive Summary
Center for the Evaluation of Risks to Human Reproduction concludes there is "negligible concern" for adverse reproductive and developmental effects from exposure to acrylamide in the general population and there is "minimal concern" for acrylamide-induced heritable effects. There is "some concern" for adverse reproductive and developmental effects from occupational exposure to the chemical, the panel says. CERHR assessed the safety of acrylamide, an ingredient used in some cosmetics, during a meeting in May (1"The Rose Sheet" May 17, 2004, p. 9). The expert panel report from this evaluation will be available in about four weeks...
You may also be interested in...
CERHR Expert Panel To Review Acrylamide Safety
Human exposure to acrylamide through dermal contact with cosmetics and other consumer products is possible because the polyacrylamide used in these products may contain free acrylamide, the National Toxicology Program Center for the Evaluation of Risks to Human Reproduction states in a 1draft report on the chemical
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.
Lilly Can Rest Easy As Tirzepatide Scores Phase III Sleep Apnea Win
Topline results from two studies in obstructive sleep apnea among obese adults showed efficacy crossing the 50% threshold that physicians have called clinically meaningful.